Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fibromyalgia Trial Endpoints Should Be Validated In Real Time – FDA Cmte.

Executive Summary

Endpoints of fibromyalgia efficacy trials should be validated in "real time" with pain as one of the primary outcome measures, FDA's Arthritis Advisory Committee recommended June 23
Advertisement

Related Content

Statistics Bedeviled Cymbalta Fibromyalgia NDA, Derail Chronic Pain Claim
Statistics Bedeviled Cymbalta Fibromyalgia NDA, Derail Chronic Pain Claim
Cymbalta Finds Divergent FDA, European Standards For Fibromyalgia Approval
Cymbalta Finds Divergent FDA, European Standards For Fibromyalgia Approval
Pfizer To Audit Managed Care Grants Under Lipitor “Best Price” Settlement
Pfizer To Audit Managed Care Grants Under Lipitor “Best Price” Settlement
Advertisement
UsernamePublicRestriction

Register

PS042042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel